Epidermal growth factor receptor specific immunotherapy for SHH medulloblastoma tested in an in vitro blood-brain barrier-model
Despite advances in treating pediatric malignant tumors like SHH-medulloblastoma (SHH-MB), the current standard of care remains surgery followed by chemo- and radiotherapy. This aggressive therapy goes along with a significant morbidity with many long-term side effects, especially in children and ad...
Saved in:
| Main Authors: | Christina Krüger, Petros Paplomatas, Naomé Kreuter, Malte Hellwig, Alicia Eckhardt, Christian Conze, Leticia Oliveira-Ferrer, Jacqueline Tischendorf, Vanessa Thaden, Ulrich Schüller, Judith Niesen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Cancer Treatment and Research Communications |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294225000863 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor-associated macrophages correlate with better outcome in SHH medulloblastoma
by: Jin Zhang, et al.
Published: (2025-04-01) -
Aberrant FGF signaling promotes granule neuron precursor expansion in SHH subgroup infantile medulloblastoma
by: Odessa R Yabut, et al.
Published: (2025-01-01) -
Immunohistochemical detection of 5-hydroxymethylcytosine as a prognostic biomarker in non-WNT/Non-SHH medulloblastomas
by: Han-Guang Zhao, et al.
Published: (2025-05-01) -
Multifocal medulloblastoma in an adult: a case report and review of the literature
by: Cha Luo, et al.
Published: (2025-05-01) -
Extraneural metastases in medulloblastoma
by: V M F Muoio, et al.
Published: (2011-01-01)